Skip to main content
. 2020 Feb 26;11:134. doi: 10.3389/fneur.2020.00134

Table 2.

Univariate analysis across patient characteristics.

Parameter Acute stroke
(n = 76)
Stroke mimic
(n = 135)
P-value (OR, 95% CI)
Age (Years) Median: 70 (28–93) Median: 69 (19–91) 0.007
Sex (M:F) 33:43 65:70 0.321 (0.75, 0.43–1.32)
Co-morbidities: n (%)
DM 29 (38.16) 54 (40) 0.793 (0.96, 0.52–1.65)
A. fib 30 (39.47) 26 (19.26) 0.001 (2.73, 1.46–5.12)
EF < 30% 16 (21.05) 8 (5.92) 0.001 (4.23, 1.72–10.44)
Clinical scenario: n (%)
Within 6 h. of HD 1 (1.31) 7 (5.18) 0.263 (0.24, 0.29–2.02)
Sedation 11 (14.47) 39 (28.89) 0.018 (0.42, 0.19–0.87)
Anti-coagulation 27 (35.53) 27 (20) 0.013 (2.20, 1.17–4.14)
Anti-platelet 32 (42.11) 49 (36.29) 0.405 (1.28, 0.72–2.27)
Post-operative 35 (46.05) 39 (28.89) 0.012 (2.10, 1.17–3.77)
Elevated level of care 29 (38.16) 41 (30.37) 0.249 (1.42, 0.78–2.55)
Witnessed seizure 1 (1.31) 20 (14.81) 0.002 (0.77, 0.01–0.58)
Symptoms: n (%)
AMS 44 (57.89) 90 (66.67) 0.204 (0.68, 0.38–1.23)
LOC 10 (13.16) 25 (18.52) 0.315 (0.67, 0.30–1.47)
Field-cut 17 (22.37) 11 (8.15) 0.003 (3.25, 1.43–7.37)
Gaze deviation 6 (7.89) 11 (8.15) 0.984 (0.96, 0.34–2.72)
Aphasia 38 (50) 61 (45.18) 0.501 (1.21, 0.69–2.13)
Neglect 10 (13.16) 5 (3.70) 0.010 (3.94, 1.29–11.9)
Dysarthria 39 (51.31) 64 (47.41) 0.586 (1.17, 0.66–2.05)
Motor symptoms 45 (59.21) 79 (58.51) 0.992 (1.03, 0.58–1.82)
Sensory symptoms 33 (43.42) 41 (30.37) 0.057 (1.76, 0.98–3.15)
Ataxia 5 (6.58) 2 (1.48) 0.101 (4.68, 0.88–24.7)
Facial droop 32 (42.11) 28 (20.74) 0.001 (2.78, 1.50–5.15)
Dizziness 5 (6.58) 8 (5.92) 1.000 (1.12, 0.35–3.56)
NIHSS Median: 6 (0–33) Median: 4 (0–34) 0.062
LSN Median: 60 (1–1,140) Median: 45 (1–1,380) 0.092

AMS, altered mental status; A. fib, atrial fibrillation; CI, confidence interval; DM, diabetes mellitus; EF, ejection fraction; F, female; HD, hemodialysis; M, male; LOC, loss of consciousness; LSN, last seen normal; OR, odds ratio.